Erratum: Long-term oral anticoagulation therapy and the risk of hip fracture in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation (Cerebrovascular Diseases (2010) 29 (73-78) DOI: 10.1159/000256650);Long-term oral anticoagulation therapy and the risk of hip fracture in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation

Cerebrovascular Diseases

Volumn 29, Issue 1, 2010, Pages 73-78

  Sato, Yoshihiro ^a   Honda, Yoshiaki ^a   Jun, Iwamoto ^b  

^a Mitate Hospital   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Hip fracture; Nonrheumatic atrial fibrillation; Vitamin K; Warfarin

Indexed keywords

25 HYDROXYVITAMIN D; OSTEOCALCIN; VITAMIN K GROUP; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BONE DENSITY; BRAIN INFARCTION; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEMISPHERE; HIP FRACTURE; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METACARPAL BONE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT DURATION;

EID: 70449504582     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000501707     Document Type: Erratum

References (44)

1. Shahar E, McGovern PG, Sprafka JM, Pankow JS, Doliszny KM, Luepker RV, Blackburn H: Improved survival of stroke patients during the 1980s. The Minnesota stroke survey. Stroke 1995; 21: 1-6.
2. Mulley G, Espley AJ: Hip fracture after hemiplegia. Postgrad Med J 1979; 55: 264-265.
3. Dennis MS, Lo KM, McDowall M, West T: Fractures after stroke: frequency, types, and associations. Stroke 2002; 33: 728-734.
4. Kanis J, Oden A, Johnell O: Acute and longterm increase in fracture risk after hospitalization for stroke. Stroke 2001; 32: 702-706.
5. Ramnemark A, Nyberg L, Borssén B, Olsson T, Gustafson Y: Fractures after stroke. Osteoporos Int 1998; 8: 92-95.
6. Brown DL, Morgenstern LB, Majersik JJ, Kleerekoper M, Lisabeth LD: Risk of fractures after stroke. Cerebrovasc Dis 2008; 25: 95-99.
7. Carda S, Cisari C, Invernizzi M, Bevilacqua M: Osteoporosis after stroke: a review of the causes and potential treatments. Cerebrovasc Dis 2009; 28: 191-200.
8. Grisso JA, Kelsey JL, Strom BL, Chiu GY, Maislin G, O'Brien LA, Hoffman S, Kaplan F: Risk factors for falls as a cause of hip fracture in women. N Engl J Med 1991; 324: 1326-1331.
9. Chiu KY, Pun WK, Luk KDK, Chow SP: A prospective study on hip fractures in patients with previous cerebrovascular accidents. Injury 1992; 23: 297-299.
10. Sato Y, Maruoka H, Honda Y, Asoh T, Fujimatsu Y, Oizumi K: Development osteopenia in the hemiplegic finger in patients with stroke. Eur Neurol 1996; 36: 278-283. (Pubitemid 26261658)
11. Sato Y, Maruoka H, Oizumi K, Kikuyama M: Vitamin D deficiency and osteopenia in the hemiplegic limbs of stroke patients. Stroke 1996; 27: 2183-2187. (Pubitemid 26427189)
12. Vermeer C, Jie KSG, Knapen MHJ: Role of vitamin K in bone metabolism. Annu Rev Nutr 1995; 15: 1-22.
13. Shearer MJ: Vitamin K. Lancet 1995; 345: 229-234.
14. Szulc P, Arlot M, Chapuy MC, Meunier PJ, Delmas PD: Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 1994; 9: 1591-1595.
15. Szulc P, Chapuy MC, Meunier PJ, Delmas PD: Serum under carboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993; 91: 1769-1774.
16. Hart JP, Shearer MJ, Klenerman L, Catterall A, Reeve J, Sambrook PN, Dodds RA, Bitensky L, Chayen J: Electrochemical detection of depressed circulating levels of vitamin K 1 in osteoporosis. J Clin Endocrin Metab 1985; 60: 1268-1269.
17. Bitensky L, Hart JP, Catterall A, Hodges SJ, Pilkington MJ, Chayen J: Circulating vitamin K levels in patients with fractures. J Bone Joint Surg Br 1988; 70:663-664.
18. Hodges SJ, Pilkington MJ, Stamp TCB, Catterall A, Shearer MJ, Bitensky L, Chayen J: Depressed levels of circulation menaquinones in patients with osteoporotic fractures of the spine and femoral neck. Bone 1991; 12: 387-389.
19. Hodges SJ, Akesson K, Vergnaud P, Obrant K, Delmas PD: Circulating levels of vitamin K 1 and K 2 decreased in elderly women with hip fractures. J Bone Miner Res 1993; 8: 1241-1245.
20. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators: The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505-1511.
21. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C: Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991; 18: 349-355.
22. Ezekowittz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazarian SM, Radford MJ, Rickles FR, Shabetai R, Deykin D: Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 1993; 328: 1406-1412.
23. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B: Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1989;1:175-179.
24. Stroke Prevention in Atrial Fibrillation Investigators: Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. N Engl J Med 1990; 322: 863-868.
25. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation 1991; 84: 527-539.
26. EAFT (European Atrial Fibrillation Trial) Study Group: Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1255-1262.
27. The European Atrial Fibrillation Trial Study Group: Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995; 333: 5-10.
28. Price PA, Williamson MK: Effects of warfarin on bone. J Biol Chem 1981; 256: 12754-12759.
29. Fiore CE, Tamburino C, Foti R, Grimaldi D: Reduced axial bone mineral content in patients with taking an oral anticoagulant. South Med J 1990; 83: 538-542.
30. Philip WJU, Martin JC, Richardson JM, Reid DM, Webster J, Douglas AS: Decreased axial and peripheral bone density in patients with taking long-term warfarin. Q J Med 1995; 88: 635-640.
31. Booth SL, Mayer J: Warfarin use and fracture risk. Nutr Rev 2000; 58: 20-22.
32. Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF: Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Arch Intern Med 2006; 166: 241-246.
33. Sato Y, Honda Y, Kuno H, Oizumi K: Longterm oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation. Stroke 1997; 28: 2390-2394.
34. Ogata T, Yasaka M: Prevention of brain infarction in patients with atrial fibrillation. Brain Nerve 2007; 59: 53-58.
35. Mahoney FI, Barthel DW: Functional evaluation: the Barthel index. Md St Med J 1965; 14: 61-65.
36. Scandinavian Stroke Study Group: Multicenter trial of hemodilution in ischemic stroke-Background and study protocol. Stroke 1985; 16: 885-890.
37. Mastumoto C, Kushida K, Yamazaki K, Imose K, Inoue T: Metacarpal bone mass in normal and osteoporotic Japanese women using computed X-ray densitometry. Calcif Tissue Int 1994; 55: 324-329.
38. Sato Y, Metoki N, Iwamoto J, Satoh K: Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in stroke patients. Neurology 2003: 61; 338-342.
39. Bügel S: Vitamin K and bone health in adult humans. Vitam Horm 2008; 78: 393-416.
40. Hirao M, Hashimoto J, Ando W, Ono T, Yoshikawa H: Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K 2 in postmenopausal women. J Bone Miner Metab 2008; 26: 260-264.
41. Sagawa A: Undercarboxylated osteocalcin. Rheumatism 2007; 37; 501-506.
42. Bügel S: Vitamin K and bone health in adult humans. Vitam Horm 2008; 78: 393-416.
43. Tsugawa N, Shiraki M, Suhara Y, Kamao M, Tanaka K, Okano T: Vitamin K status of healthy Japanese women: age-related vitamin K requirement for gamma-carboxylation of osteocalcin. Am J Clin Nutr 2006; 83: 380-386.
44. Caraballo PJ, Heit JA, Atkinson EJ, Silverstein MD, O'Fallon WM, Castro MR, Melton LJ 3rd: Long-term use of oral anticoagulants and the risk of fracture. Arch Intern Med 1999; 159: 1750-1756.